Are expensive vaccines the best investment in lower-middle income countries?

Lone Simonsen, Maarten van Wijhe, Robert J. Taylor

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalThe Lancet Global Health
Volume7
Issue number5
Pages (from-to)E548-E549
Number of pages2
ISSN2214-109X
DOIs
Publication statusPublished - 1 May 2019

Bibliographical note

Invited commentary

Cite this

@article{c6f135888b3c41b18ea02366f163965c,
title = "Are expensive vaccines the best investment in lower-middle income countries?",
author = "Lone Simonsen and Wijhe, {Maarten van} and Taylor, {Robert J.}",
note = "Invited commentary",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/S2214-109X(19)30040-3",
language = "English",
volume = "7",
pages = "E548--E549",
journal = "The Lancet Global Health",
issn = "2214-109X",
publisher = "The Lancet Publishing Group",
number = "5",

}

Are expensive vaccines the best investment in lower-middle income countries? / Simonsen, Lone; Wijhe, Maarten van; Taylor, Robert J.

In: The Lancet Global Health, Vol. 7, No. 5, 01.05.2019, p. E548-E549.

Research output: Contribution to journalComment/debateResearchpeer-review

TY - JOUR

T1 - Are expensive vaccines the best investment in lower-middle income countries?

AU - Simonsen, Lone

AU - Wijhe, Maarten van

AU - Taylor, Robert J.

N1 - Invited commentary

PY - 2019/5/1

Y1 - 2019/5/1

U2 - 10.1016/S2214-109X(19)30040-3

DO - 10.1016/S2214-109X(19)30040-3

M3 - Comment/debate

VL - 7

SP - E548-E549

JO - The Lancet Global Health

JF - The Lancet Global Health

SN - 2214-109X

IS - 5

ER -